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Background/aim: The effects of coadministration of melatonin and theanine (Mel/Thea) on pentylenetetrazole (PTZ)-induced seizures
and brain tissue oxidative damage were investigated in ovariectomized (OVX) and sham-operated rats.
Materials and methods: The rats were divided into the following groups: 1) sham, 2) ovariectomized (OVX), 3) sham-PTZ, 4) OVXPTZ, 5) sham-Mel/Thea-PTZ, and 6) OVX-Mel/Thea-PTZ. Groups 1–4 received saline, while groups 5 and 6 received a combination of
Mel/Thea for 6 weeks. All animals except for those in groups 1 and 2 received a single injection of PTZ.
Results: The OVX-PTZ group had higher generalized tonic-clonic seizure (GTCS) latency compared to the sham-PTZ group.
Administration of Mel/Thea increased minimal clonic seizure and GTCS latencies in both the sham-Mel/Thea-PTZ and OVX-Mel/TheaPTZ groups compared to the controls. Additionally, PTZ exposure increased malondialdehyde levels and reduced thiol concentrations
in brain tissues of both the sham-PTZ and OVX-PTZ groups. Mel/Thea pretreatment resulted in MDA reduction and thiol increase in
brain tissues.
Conclusion: The results of this study demonstrated the antioxidant and anticonvulsant activities of Mel/Thea despite the presence or
absence of ovarian hormones.
Key words: Melatonin, theanine, pentylenetetrazole, seizures, oxidative stress, brain, rat

1. Introduction
Epilepsy is a common neurological disease that affects
approximately 1% of the population (1). It is characterized
by abnormal episodic bursts of electrical activity in neurons,
which significantly impact the cognitive processes and
behavior of the affected patients (2). The central nervous
system (CNS) is very susceptible to oxidative injury
due to high levels of membrane lipid constituents (3,4).
Accumulating evidence has revealed an important role
for oxidative stress, both as a consequence and as a cause
of epileptic seizures (5). It has been found that prolonged
seizures increase the production of free radicals (6) and
result in oxidative damage to lipids, DNA, and susceptible
proteins (7). Moreover, it has been shown that reactive
* Correspondence: hosseinim@mums.ac.ir
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oxygen species (ROS) may underlie the neurotoxic effects
of some convulsant agents, such as pentylenetetrazole
(PTZ) (8). Furthermore, it has been demonstrated that
the antioxidative properties of melatonin, vineatrol,
trans-resveratrol, and alpha-lipoic acid are associated
with their anticonvulsant effects (6,9). Collectively, it
appears that using antioxidants is a promising approach
in the development of new therapeutic agents with
neuroprotective effects against epileptic seizures (5,7).
Additionally, it has been well documented that female
sex hormones play a role in epilepsy (10,11). There are
also close communications and connections between
the hypothalamus and pituitary gland, which regulate
sex hormone secretion, and the temporal lobes, which
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are important areas in seizures (12). Female epileptics
frequently show exacerbated symptoms at specific
points during their menstrual cycle, for example during
periods of low progesterone levels (10). It has also been
found that progesterone reduces neuronal activity, while
estrogen increases neuronal excitability (11). In fact,
previous studies demonstrated that low progesterone levels
are associated with increased seizure frequency in women
(13). Elevated estrogen levels during perimenopause
also appear to exacerbate epilepsy (13). It has also has
been observed that testosterone and its metabolites have
antiseizure effects in men (14). These findings collectively
suggest the potential influence of sexual hormones on
seizure susceptibility.
On the other hand, some dietary components with
antioxidative properties have shown neuroprotective effects.
For instance, L-theanine (gamma-glutamylethylamide),
a unique amino acid present almost exclusively in tea, has
demonstrated antioxidative and neuroprotective effects
(15,16). Previous studies have shown that L-theanine
increases brain serotonin, dopamine, and gamma amino
butyric acid (GABA) levels; improves memory function;
and has a neuroprotective effect in several animal models
of neurological disorders (17,18).
Additionally, some neuroagents with antioxidative
properties, such as melatonin, were demonstrated to
have neuroprotective effects in previous studies (19–
23). Melatonin, an indoleamine derivative of serotonin
produced by the pineal gland, has shown antioxidative,
sedative, anticonvulsive, and hypnotic effects in the CNS of
mammals (19,21–23). In rats, melatonin has anticonvulsant
and inhibitory effects on the glutamate-mediated response
of the striatum to motor cortex stimulation (20). Melatonin
also depresses brain excitability and prevents seizures (6).
It has been well documented that melatonin influences
reproductive hormones both in males and females (24,25).
It has been shown that melatonin decreases estrogen levels
while increasing the progesterone concentrations in rats
(26).
The objective of the present study was to evaluate the
effects of the administration of a combination of melatonin
and theanine on seizures and oxidative brain tissue damage
induced by PTZ in ovariectomized (OVX) rats.
2. Materials and methods
2.1. Drugs and chemicals
PTZ, melatonin, and theanine were purchased from SigmaAldrich (St. Louis, MO, USA). Other chemical compounds
such as thiobarbituric acid (TBA), trichloroacetic acid
(TCA), 2,2’-dinitro-5,5’-dithiodibenzoic acid (DTNB),
ethylenediaminetetraacetic acid (EDTA), and hydrochloric
acid (HCl) were bought from Merck (Kenilworth, NJ,
USA).

2.2. Animal groups
Forty-eight virgin female Wistar rats (230 ± 20 g in weight)
were maintained in an animal house under controlled
conditions, including 12-h light/dark cycle, 22–24 °C temperature, and appropriate humidity, with laboratory chow
and water provided ad libitum. The study protocol using
the laboratory rats complied with the general guidelines
of animal care of Mashhad University of Medical Sciences,
Iran.
The animals were acclimatized for 15 days and then
were ovariectomized under ketamine anesthesia (150 mg/
kg, i.p.) (27–30). Anesthesia was confirmed by a reduced
respiratory rate and a lack of response to the gentle
pinching of the foot pad. Abdominal incisions were made
through the skin of the flank of the rats, and the ovaries
and ovarian fats were removed. Ovaries were isolated by
ligation of the most proximal portion of the oviduct before
removal. The same procedure was performed on the rats in
the sham group, except that the wound was closed without
removing the ovaries (31–33).
Animals were divided into the following 6 groups
(n = 8): 1) sham, 2) OVX, 3) sham-PTZ, 4) OVX-PTZ,
5) sham-Mel/Thea-PTZ, and 6) OVX-Mel/Thea-PTZ.
The animals in groups 1–4 were treated with saline daily
(2 mL/kg) for 6 weeks, while groups 5 and 6 received a
combination of melatonin and theanine (Mel/Thea; 3
mg and 25 mg/kg) intraperitoneally daily for 6 weeks.
After 6 weeks of saline or Mel/Thea injections, animals
in groups 3–6 received a single injection of PTZ (90 mg/
kg, i.p.). Minimal clonic seizure (MCS) and generalized
tonic-clonic seizure (GTCS) latencies, as ictal behaviors,
were then measured (34–37). Finally, the animals were
sacrificed, and the cortical and hippocampal tissues were
removed for biochemical analyses.
2.3. PTZ-induced seizures
In order to assess the ictal behavior, animals were placed
in a Plexiglas arena (30 cm × 30 cm × 30 cm) after
PTZ injection and were observed for 60 min after PTZ
administration. Behavioral responses of the animals to
PTZ were evaluated using the following criteria: latency to
the first MCS, incidence of MCS, latency to the first GTCS,
incidence of GTCS, and mortality percentage (34–36).
2.4. Biochemical assessment
After behavioral assessments, the animals were
sacrificed and the brains were removed. The cortical and
hippocampal regions were dissected on an ice-cold surface
and homogenized in ice-cold phosphate-buffered saline
to give 10% homogeny. Total SH groups were measured
using DTNB as the reagent. This reagent reacts with the
thiol groups to produce a yellow complex that has peak
absorbance at 412 nm. Briefly, 1 mL of Tris-EDTA buffer
(pH 8.6) was added to 50 µL of brain homogenate in
1-mL cuvettes, and sample absorbance was read at 412
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nm against Tris-EDTA buffer alone (A1). Then 20 µL of
DTNB reagent (10 mM in methanol) was added to the
mixture. The mixture was incubated at room temperature
for 15 min, and then the sample absorbance was read again
(A2). The absorbance of DTNB reagent was also read as the
blank (B). Total thiol concentration (mM) was calculated
using the following equation (37–40):
total thiol concentration (mM) = (A2 − A1 − B) × 1.07/
(0.05 × 13.6).
Malondialdehyde (MDA) levels, as an index of lipid
peroxidation, were measured in cortical and hippocampal
regions. MDA reacts with TBA as a thiobarbituric acid
reactive substance to produce a red-colored complex that
has peak absorbance at 535 nm. The TBA/TCA/HCL
reagent was added for homogenization, and the solution
was incubated in a boiling water bath for 40 min. After
cooling, the whole solution was centrifuged at 1000 × g for
10 min. The absorbance was measured at 535 nm (37–40).
The MDA concentration was calculated as follows: C (M)
= absorbance/(1.56 × 105).
2.5. Statistical analysis
All data were expressed as mean ± standard error of the
mean (SEM) and were analyzed using one-way ANOVA
followed by Tukey’s post hoc comparison test. Comparisons
between two groups were done using an unpaired t-test. P
< 0.05 was considered to be statistically significant.
3. Results
3.1. Behavioral results
PTZ exposure was associated with seizure incidence (MCS
and GTCS) in all PTZ-exposed groups. Ovariectomy
showed a protective effect in PTZ-induced seizures by
increasing the GTCS latency in the OVX-PTZ group
compared to sham-PTZ group (P < 0.01, Table 1).
However, it did not affect the MCS latency (P > 0.05, Table
1). Additionally, Mel/Thea administration significantly
increased both MCS and GTCS latencies in the sham-Mel/
Thea-PTZ group compared to the sham-PTZ group (P <
0.05, Table 1). Mel/Thea treatment had a similar effect on

OVX rats, as it increased the MCS and GTCS latencies in
the OVX-Mel/Thea-PTZ group compared to the OVXPTZ group (P < 0.01, Table 1).
3.2. Biochemical results
Ovariectomy was associated with biochemical changes in
brain tissue, which was seen in the reduced thiol contents
and increased MDA levels in the hippocampal regions of
the OVX group compared to the sham group (P < 0.001,
Table 2). PTZ exposure also resulted in a significant
reduction in thiol levels and a significant increase in
MDA concentrations in the hippocampal tissues of the
sham-PTZ group compared to the sham group (P < 0.01
and P < 0.001, respectively, Table 2). Additionally, PTZ
exposure aggravated the adverse effects of ovariectomy
on hippocampal thiol concentrations by reducing the
hippocampal thiol levels of the OVX-PTZ group compared
to the OVX group (P < 0.01); however, it did not cause a
significant difference in MDA concentrations (P > 0.05,
Table 2).
Administration of Mel/Thea improved the hippocampal
thiol levels in the sham-Mel/Thea-PTZ group (P < 0.05),
but it did not make a significant difference in hippocampal
MDA concentrations between the sham-Mel/Thea-PTZ
and sham-PTZ groups (P > 0.05, Table 2). Furthermore,
Mel/Thea administration was associated with the alteration
of both MDA and thiol levels in the hippocampal area of
the OVX-Mel/Thea-PTZ group by reducing MDA levels
(P < 0.05, Table 2) and increasing thiol concentrations
compared to the OVX-PTZ group (P < 0.001, Table 2).
In addition to biochemical alterations in the
hippocampal area, ovariectomy also caused significant
changes in MDA and thiol levels in cortical regions. OVX
rats showed reduced thiol and increased MDA levels in
cortical areas compared to the sham group (P < 0.05 and P
< 0.001, respectively, Table 3). Similarly, PTZ exposure was
associated with an increased level of cortical MDA and a
reduced level of cortical thiol in both the sham-PTZ and
OVX-PTZ groups compared to their control groups (sham
and OVX groups, respectively) (P < 0.05, Table 3).

Table 1. Comparison of MCS and GTCS latencies between the study groups.
Groups

MCS latency (s)

GTCS latency (s)

Sham-PTZ

59.4 ± 4.05

67.6 ± 5.48

Sham-Mel/Thea-PTZ

135 ± 24.09*

227.66 ± 77.73*

OVX-PTZ

105.88 ± 24.8

144.33 ± 32.75**

OVX-Mel/Thea-PTZ

262.2 ± 67.109++

416.2 ± 120.41++

All data were expressed as mean ± SEM (n= 8 in each group).
*P < 0.05, **P < 0.01 compared to sham-PTZ.
++
P < 0.01 compared to OVX-PTZ.
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Table 2. Comparison of the MDA and total thiol concentrations in hippocampal tissues between the
study groups.
Groups

MDA concentration in hippocampal
tissues (nmol/g tissue)

Thiol contents in hippocampal
tissues (mM)

Sham

9.139 ± 0.57

25.35 ± 2.27

Sham-PTZ
Sham-Mel/Thea-PTZ

16.2 ± 0.75***

14.17 ± 2.08**

13.21 ± 1.41

24.94 ± 3.52#

OVX

15.14 ± 1.42***

14.55 ± 1.87***

OVX-PTZ

14.34 ± 0.68

5.65 ± 1.52++

OVX-Mel/Thea-PTZ

10.01 ± 0.48$

22.41 ± 2.28$$$

All data were expressed as mean ± SEM (n= 8 in each group).
**P < 0.01,***P < 0.001 compared to the sham group.
++
P < 0.01 compared to the OVX group.
#P < 0.05 compared to the sham-PTZ group.
$
P < 0.05, $$$P < 0.001 compared to the OVX-PTZ group.

Table 3. Comparison of the MDA and total thiol concentrations in cortical tissues between the study
groups.
Groups

MDA concentration in cortical tissues
(nmol/g tissue)

Thiol contents in cortical
tissues (mM)

Sham

8.17 ± 0.5

21.13 ± 4.94

Sham-PTZ

16.09 ± 0.51***

3.73 ± 0.83***

Sham-Mel/Thea-PTZ

10.08 ± 0.3###

16.1 ± 3.96#

OVX

12.13 ± 0.49***

11.23 ± 2.13*

OVX-PTZ

15.79 ± 0.53+++

6.26 ± 0.66+

OVX-Mel/Thea-PTZ

10.67 ± 0.56$$$

11.44 ± 1.18$

All data were expressed as mean ± SEM (n= 8 in each group).
*P < 0.05, ***P < 0.001 compared to the sham group.
+
P < 0.05, +++P < 0.001 compared to the OVX group.
#P < 0.05, ###P < 0.001 compared to the sham-PTZ group.
$
P < 0.05, $$$P < 0.001 compared to the OVX-PTZ group.

Mel/Thea administration improved both MDA and
thiol levels in the cortical regions of the sham-Mel/TheaPTZ group compared to the sham-PTZ group (P < 0.001
and P < 0.05, respectively, Table 3). Similarly, the Mel/Thea
combination reduced the cortical MDA concentrations
while increasing thiol levels in the OVX-Mel/Thea-PTZ
group compared to the OVX-PTZ group (P < 0.05 and P
< 0.001, Table 3).

4. Discussion
Oxidative stress is involved in many neurological and
neurodegenerative disorders. Previous studies have
demonstrated an increase in free radical levels during
seizures (6), suggesting the important role of oxidative
stress in the pathogenesis of epileptic seizures (5). Similarly,
in the present study, we observed an increase in MDA
levels and a reduction in total thiol groups in the brain
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tissues of animals that had PTZ-induced seizures. It has
been well demonstrated that production of ROS, including
superoxide anions, hydroxyl radicals, and hydrogen
peroxide, increases in the brains of animals subjected to
seizures (41,42). Oxidative damage of brain tissue by free
radicals may lead to psychiatric or cognitive problems
such as depression, anxiety, and memory loss (43,44). The
reduction of the life span observed in epileptic patients
may also be partly related to neuronal oxidative damages
(45). Furthermore, oxidative stress has been suggested as
a link between aging and seizures (46). The results of the
present study also demonstrate a link between seizures
and brain tissue oxidative damage in a PTZ-induced
seizure model. This model has been frequently used to
examine the potential anticonvulsant properties of drugs
or natural compounds (34–36). PTZ decreases GABA
system function and increases the activity of the glutamate
neurotransmission system (47). One of the suggested
mechanisms for the neurotoxic effects of PTZ is the ROSinduced oxidative damage in the CNS (48,49).
Previously, several in vivo and in vitro studies
demonstrated the potential effects of theanine and
melatonin in reducing oxidative stress (16,50,51). Theanine
increases the production of GABA and dopamine, while
it protects the cells of the hippocampus, the major center
of learning and memory, from oxidative damage (17).
Moreover, in vitro studies using MDA as a marker of
lipid peroxidation demonstrated the ability of theanine to
inhibit the oxidation of low-density lipoprotein (51). In
another study, Reiter showed that melatonin has a potent
scavenging role for both ROS and reactive nitrogen species
(52). Mohanan and Yamamoto also showed that melatonin
has preventive effects on kainic acid (KA)-induced seizures
and lipid peroxidation in mice (53). Additionally, several
studies confirmed the anticonvulsant effects of melatonin
(54,55). The results of the present study demonstrated that
the combination of melatonin and theanine increases both
GTCS and MCS latencies, indicating the anticonvulsant
effects of melatonin and theanine and their ability to reduce
seizure susceptibility. The administration of the Mel/Thea
combination also resulted in a significant reduction in
MDA and in elevated thiol concentrations in brain tissues.
Consistent with our findings, some studies reported strong
antioxidant activity for theanine and melatonin (16,23),
suggesting their protective potential against brain tissues
oxidative damage. The results of the present study suggest
that the Mel/Thea combination has a protective role against
seizures and seizure-related complications; however, more
studies are needed.
Additionally, previous studies demonstrated a link
between seizures and sex hormones. For instance, it was
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shown that menopause affects seizure patterns (56). Using
OVX rats is a common model of hormone deprivation
to study the effects of postmenopausal conditions on the
CNS. In this study, ovariectomy resulted in a significant
decrease in susceptibility to PTZ-induced seizures. This
finding is consistent with previous reports showing that
ovariectomies cause a decrease in GTCS and seizure
susceptibility (36). It has been shown that estrogen has
proconvulsant effects, while progesterone has inhibitory
effects on seizure susceptibility (57,58). Galanopoulou et
al. showed that estradiol treatment decreased the seizure
threshold in female rats (59). In contrast, Hoffman et
al. reported that estrogen had no effect on KA-induced
seizures (60). Pereira et al. also reported that estrogen
replacement therapy attenuated the frequency of seizures
in a pilocarpine-induced epilepsy model (61). There is
increasing evidence that sex hormones might have a
role in seizure susceptibility (62,63); however, the exact
mechanisms are unknown. It has been well documented
that sex hormones exert their regulatory effects on
neuronal excitability by modulating neurotransmitter
receptors including GABA, N-methyl-D-aspartic acid
(NMDA), and opioid receptors, as well as by direct and/or
indirect regulation of adenosine receptors (64–67). These
mechanisms may be involved in the lower susceptibility
of OVX rats to PTZ-induced seizures in the present study.
Furthermore, several studies have demonstrated
the effect of melatonin on the sex hormones of female
rats (25,68,69). We hypothesized that the effects of Mel/
Thea on seizures may be different between OVX and
treatment-naive female rats. For this reason, the effects
of a combination of Mel/Thea on PTZ-induced seizures
in OVX and naive female rats were also investigated. The
Mel/Thea combination delayed latency of PTZ-induced
seizures and decreased oxidative damage in both naive
female and OVX rats, without a significant difference
between the two groups. It has been suggested that the
anticonvulsant effects of melatonin may be due to its
antioxidative function, neuroprotective effects, central
GABAergic transmission, and regulation of the nitric oxide
(NO) pathway (70). Mohanan and Yamamoto showed that
the scavenging of hydroxyl radicals may contribute to the
anticonvulsant effects of melatonin (53). In another study,
Acufla-Castroviejo et al. demonstrated that melatonin
increased GABA concentration in epilepsy (71). YahyaviFirouz-Abadi et al. also reported that the NO pathway is
involved in the melatonin-induced modulation of seizure
susceptibility in mice (72). These mechanisms may be
involved in the anticonvulsant effects of Mel/Thea in the
current study.
In conclusion, the results of this study demonstrated
that the administration of a combination of Mel/Thea
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increases anticonvulsant activity. These beneficial effects
are accompanied by an antioxidant effect in brain tissues.
We did not find any difference in the efficiency of Mel/
Thea between treatment-naive and OVX rats, but further
investigations are needed.
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